A lot of patients with type 2 diabetes confuse basal insulin with rapid acting insulin
According to the result of 'Blood glucose control in patients with type 2 diabetes and Survey of whether the patients know the features of insulin pen' which Novo Nordisk Pharmaceutical asked a research company Ipsos to do in the last end of 2013, it turned out that 26% of all patients confuse ba...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
